Andrew Cheng, Director at Arbutus Biopharma, holds ― shares in Arbutus Biopharma (Ticker: ABUS), holds 605.42K shares in Akero Therapeutics (Ticker: AKRO), holds 17.49K shares in Vera Therapeutics (Ticker: VERA). Most recently, Andrew Cheng ― shares of Arbutus Biopharma on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Andrew Cheng?
The percentage of profitable transactions made by Andrew Cheng is 0%.
What is the average return per transaction made by Andrew Cheng?
The average return per transaction made by Andrew Cheng is -36.80%.
What stocks does Andrew Cheng hold?
Andrew Cheng holds: ABUS, AKRO, VERA stocks.
What was Andrew Cheng’s latest transaction?
Andrew Cheng latest transaction was an Uninformative Buy of ―.
What was Andrew Cheng's most profitable transaction?
Andrew Cheng’s most profitable transaction was an Informative Sell of AKRO stock on March 15, 2024. The return on the trade was -25.00%.
What is Andrew Cheng's role in Arbutus Biopharma?
Andrew Cheng's role in Arbutus Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.